Format

Send to

Choose Destination
Rhinology. 2017 Jun 1;55(2):106-112. doi: 10.4193/Rhin16.063.

Rhinophototherapy in chronic rhinosinusitis: a double blind randomized placebo-controlled trial.

Author information

1
Department of OtoRhinoLaryngology, Head and Neck Surgery, Geneva University Hospital, Geneva, Switzerland.
2
Division of Oral and Maxillofacial Surgery, Geneva University Hospital, Geneva, Switzerland.
3
Faculty of medicine, Geneva Medical University, Geneva, Switzerland.
4
Private practice, Geneva, Switzerland.

Abstract

BACKGROUND:

This study evaluated the efficacy of rhinophototherapy in patients with chronic rhinosinusitis (CRS) without nasal polyps.

METHOD:

In this randomized double-blind, placebo-controlled trial, CRS patients (n=50) received either mixed visible and ultraviolet (UVA and UVB) light source application (mUV/VIS) or visible light alone that served as placebo. Both groups were treated for 3 weeks.

RESULTS:

Results in the rhinophototherapy and placebo group were not significantly different and failed to reduce patient-reported outcomes measures (Rhinosinusits Disability Index, Visual Analogic Scale of symptom severity) and objective scores (rhinomanometry, olfactory thresholds, nasal Nitic Oxide concentrations), immediately and one month after treatment.

CONCLUSIONS:

The present data suggest that rhinophototherapy is not an efficient treatment for chronic rhinosinusitis without nasal polyps.

PMID:
28501886
DOI:
10.4193/Rhin16.063
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for International Rhinologic Society
Loading ...
Support Center